|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 6
Zeitschriftenartikel
Weiss, L.; Karthaus, M.; Riera-Knorrenschild, J.; Kretzschmar, A.; Welslau, M.; Vehling-Kaiser, U.; Pelz, H.; Ettrich, T. J.; Hess, J.; Reislaender, T.; Klein, A. und Heinemann, V
(2022):
Efficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial.
In: Esmo Open, Bd. 7, Nr. 1
[PDF, 367kB]
Sommerhäuser, G.; Kurreck, A.; Stintzing, S.; Heinemann, V.; Fischer von Weikersthal, L.; Dechow, T.; Kaiser, F.; Karthaus, M.; Schwaner, I.; Fuchs, M.; König, A.; Roderburg, C.; Hoyer, I.; Quante, M.; Kiani, A.; Fruehauf, S.; Müller, L.; Reinacher-Schick, A.; Ettrich, T. J.; Stahler, A. und Modest, D. P.
(2022):
Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer.
In: BMC Cancer, Bd. 22, Nr. 1, 820
Karthaus, M.; Kröning, H.; Bauer, S.; Brandt, K. und Heinemann, V.
(2017):
Safety and quality-of-life in patients treated with aflibercept and FOLFIRI as 2nd line treatment for their metastatic colorectal cancer (mCRC) - a German subgroup analysis of the Aflibercept Safety and Quality-of-Life Program (ASQoP).
In: Oncology Research and Treatment, Bd. 40: S. 167-168
Heinz, W. J.; Buchheidt, D.; Christopeit, M.; Lilienfeld-Toal, M. von; Cornely, O. A.; Einsele, H.; Karthaus, M.; Link, H.; Mahlberg, R.; Neumann, S.; Ostermann, H.; Penack, O.; Ruhnke, M.; Sandherr, M.; Schiel, X.; Vehreschild, J. J.; Weissinger, F. und Maschmeyer, G.
(2017):
Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
In: Annals of Hematology, Bd. 96, Nr. 11: S. 1775-1792
Michl, M.; Thurmaier, J.; Schubert-Fritschle, Gabriele; Wiedemann, Max; Laubender, Rüdiger P.; Nussler, N. C.; Ruppert, R.; Kleeff, J.; Schepp, W.; Reuter, C.; Lohe, F.; Karthaus, M.; Neumann, J.; Kirchner, T.; Engel, Jutta und Heinemann, V.
(2015):
Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
In: Clinical Colorectal Cancer, Bd. 14, Nr. 4: S. 281-290
Karthaus, M.; Buchheidt, D.; Hiddemann, Wolfgang; Donnelly, J. P.; Krcmery, V.; Schiel, X.; Wilhelm, M. und Helmerking, M.
(1999):
European surveillance of infections in cancer patients - ESIC.
In: Chemotherapy, Nr. 4: S. 237-241
[PDF, 193kB]